Man Group
SLNO

Man Group’s Soleno Therapeutics SLNO Stock Holding History

Man Group’s Portfolio SLNO Stock Details SLNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,678
Closed -$692K – 2586
2026
Q1 		$692K Buy
20,678
+5,631
+37% +$221K ﹤0.01% 1965
2025
Q4 		$697K Buy
15,047
+3,555
+31% +$195K ﹤0.01% 1788
2025
Q3 		$777K Buy
+11,492
New +$852K ﹤0.01% 1752

Man Group's SLNO Position: Q2 2026 in Review

Man Group sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 20,678 shares — an estimated $692K sold.

Man Group first reported a position in SLNO in Q3 2025 and held it in 3 quarters. The position peaked at $777K in Q3 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

  • Man Group reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Man Group sold 20,678 Soleno Therapeutics shares in Q2 2026, an estimated $692K.
  • Man Group first reported a position in Soleno Therapeutics in Q3 2025 and held it in 3 quarters.
  • Man Group's Soleno Therapeutics position peaked at $777K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.